{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:10:57Z","timestamp":1790201457192,"version":"4.1.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.10.075","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T03:39:31Z","timestamp":1541216371000},"page":"333-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"C","title":["Fungal vaccines, mechanism of actions and immunology: A comprehensive review"],"prefix":"10.1016","volume":"109","author":[{"given":"Sanam","family":"Nami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Khezripour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Morovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.micinf.2012.11.007","article-title":"DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells","volume":"15","author":"de Amorim","year":"2013","journal-title":"Microbes Infect."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1099\/jmm.0.041665-0","article-title":"Fungal cell wall vaccines: an update","volume":"61","author":"Edwards","year":"2012","journal-title":"J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/0929866524666170807125245","article-title":"Candida Infections and Human Defensins","volume":"24","author":"Polesello","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.biopha.2018.10.075_bib0020","series-title":"Immunodeficiency","author":"Justiz","year":"2018"},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0025","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1590\/0074-02760150335","article-title":"New insights on the development of fungal vaccines: from immunity to recent challenges","volume":"110","author":"Medici","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2018.10.075_bib0030","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0378-3782(12)70004-X","article-title":"Neonatal fungal infections: when to treat?","volume":"88","author":"Hsieh","year":"2012","journal-title":"Early Hum. Dev."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12879-016-1704-y","article-title":"Factors related to outcome of bloodstream infections due to Candida parapsilosis complex","volume":"16","author":"Barchiesi","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biopha.2018.10.075_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2373424","article-title":"Spectrum of opportunistic fungal infections in HIV\/AIDS patients in tertiary care hospital in India","volume":"2016","author":"Kaur","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.biopha.2018.10.075_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/471363","article-title":"New insights into HIV\/AIDS-associated cryptococcosis","volume":"2013","author":"Antinori","year":"2013","journal-title":"ISRN AIDS"},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1473-3099(17)30442-5","article-title":"Immunotherapeutic approaches to treatment of fungal diseases","volume":"17","author":"Armstrong-James","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"36","key":"10.1016\/j.biopha.2018.10.075_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-042617-053318","article-title":"Host control of fungal infections: lessons from basic studies and human cohorts","volume":"26","author":"Lionakis","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2018.10.075_bib0060","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fimmu.2014.00506","article-title":"Antifungal Th immunity: growing up in family","volume":"5","author":"Borghi","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2018.10.075_bib0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fmicb.2015.00625","article-title":"Host-pathogen interactions between the human innate immune system and Candida albicans\u2014understanding and modeling defense and evasion strategies","volume":"6","author":"D\u00fchring","year":"2015","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0070","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0050-2016","article-title":"Fungal recognition and host defense mechanisms","volume":"5","author":"Dambuza","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biopha.2018.10.075_bib0075","series-title":"Pattern Recognition Receptors in Fungal Immunity. In Seminars in Cell & Developmental Biology","author":"Patin","year":"2018"},{"key":"10.1016\/j.biopha.2018.10.075_bib0080","unstructured":"Morovati H., et al., The effect of cyclophosphamide on TLR2 gene expression in Balb\/c Mice with systemic candidiasis. 2016. 34(389): p. 771\u2013776."},{"key":"10.1016\/j.biopha.2018.10.075_bib0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.micpath.2018.04.026","article-title":"TLR-2, IL-10 and IL-17-mediated immunity in experimental chemotherapy murine model of systemic candidiasis; cyclophosphamides\u2019 impact and roles","volume":"119","author":"Dehghan","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.biopha.2018.10.075_bib0090","first-page":"1","article-title":"Antifungal innate immunity: a perspective from the last 10 years","author":"Salazar","year":"2018","journal-title":"J. Innate Immun."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chom.2012.04.005","article-title":"Dendritic cells in antifungal immunity and vaccine design","volume":"11","author":"Roy","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0105","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/jof3040060","article-title":"Innate immunity to mucosal Candida infections","volume":"3","author":"Verma","year":"2017","journal-title":"J. Fungi"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/jof3030047","article-title":"Immune recognition of fungal polysaccharides","volume":"3","author":"Snarr","year":"2017","journal-title":"J. Fungi"},{"key":"10.1016\/j.biopha.2018.10.075_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2018.04.010","article-title":"Impact of fungi on immune responses","author":"Conti","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2018.10.075_bib0125","series-title":"The Human Immune Response, in Clinical Immunology","first-page":"3","author":"Rich","year":"2019"},{"key":"10.1016\/j.biopha.2018.10.075_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2012.00156","article-title":"Immunity and tolerance to fungi in hematopoietic transplantation: principles and perspectives","volume":"3","author":"Carvalho","year":"2012","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1348-0421.12560","article-title":"Interleukin\u201017 family cytokines in protective immunity against infections: role of hematopoietic cell\u2010derived and non\u2010hematopoietic cell\u2010derived interleukin\u201017s","volume":"62","author":"Matsuzaki","year":"2018","journal-title":"Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.075_bib0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.it.2012.04.008","article-title":"From memory to antifungal vaccine design","volume":"33","author":"Iannitti","year":"2012","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s13311-016-0453-3","article-title":"Vaccinations for neuroinfectious disease: a global health priority","volume":"13","author":"Leibovitch","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: vaccines on the threshold","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1473-3099(08)70016-1","article-title":"Fungal vaccines: real progress from real challenges","volume":"8","author":"Cassone","year":"2008","journal-title":"Lancet Infect. Dis."},{"issue":"27","key":"10.1016\/j.biopha.2018.10.075_bib0160","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1016\/j.vaccine.2009.03.030","article-title":"Saccharomyces cerevisiae as a vaccine against coccidioidomycosis","volume":"27","author":"Capilla","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0165","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.075_bib0170","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2010.12.119","article-title":"Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/08820139.2012.692418","article-title":"Saccharomyces as a vaccine against systemic candidiasis","volume":"41","author":"Liu","year":"2012","journal-title":"Immunol. Invest."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0180","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1567-1364.2010.00665.x","article-title":"Vaccines based on whole recombinant Saccharomyces cerevisiae cells","volume":"10","author":"Ardiani","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.biopha.2018.10.075_bib0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.micro.59.030804.121055","article-title":"Defining virulence genes in the dimorphic fungi","volume":"60","author":"Rappleye","year":"2006","journal-title":"Annu. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccm.2009.02.003","article-title":"Blastomycosis: new insights into diagnosis, prevention, and treatment","volume":"30","author":"McKinnell","year":"2009","journal-title":"Clin. Chest Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/13693780500245875","article-title":"Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity","volume":"43","author":"Deepe","year":"2005","journal-title":"Med. Mycol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1369-5274(00)00100-4","article-title":"Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion","volume":"3","author":"Klein","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0205","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts","volume":"197","author":"W\u00fcthrich","year":"2003","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0210","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1084\/jem.189.8.1207","article-title":"Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis","volume":"189","author":"Brandhorst","year":"1999","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0215","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI11037","article-title":"Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance","volume":"106","author":"W\u00fcthrich","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0220","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.66.11.5443-5449.1998","article-title":"Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis","volume":"66","author":"W\u00fcthrich","year":"1998","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0225","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1128\/IAI.68.12.7172-7174.2000","article-title":"Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to blastomyces dermatitidis infection","volume":"68","author":"W\u00fcthrich","year":"2000","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0230","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/CVI.00036-11","article-title":"Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice","volume":"18","author":"Wozniak","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0240","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019711","article-title":"Fungal vaccines and immunotherapeutics","volume":"4","author":"Santos","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0245","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2460\/ajvr.1986.47.11.2415","article-title":"Vaccination of cattle against ringworm caused by Trichophyton verrucosum","volume":"47","author":"Gudding","year":"1986","journal-title":"Am. J. Vet. Res."},{"issue":"40","key":"10.1016\/j.biopha.2018.10.075_bib0250","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1016\/j.vaccine.2015.04.099","article-title":"Molecular signatures of vaccine adjuvants","volume":"33","author":"Olafsdottir","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0255","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.02.012","article-title":"Beyond empiricism: informing vaccine development through innate immunity research","volume":"148","author":"Levitz","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.10.075_bib0260","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0265","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)","volume":"51","author":"Control, C.f.D. and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.biopha.2018.10.075_bib0270","series-title":"Principles of vaccination. Vaccine Design: Methods and Protocols: Volume 1: Vaccines for Human Diseases","first-page":"57","author":"Zepp","year":"2016"},{"issue":"52","key":"10.1016\/j.biopha.2018.10.075_bib0275","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2016.10.016","article-title":"Vaccine development: from concept to early clinical testing","volume":"34","author":"Cunningham","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0280","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pbio.0050064","article-title":"Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells","volume":"5","author":"Phan","year":"2007","journal-title":"PLoS Biol."},{"issue":"52","key":"10.1016\/j.biopha.2018.10.075_bib0285","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0290","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis","volume":"194","author":"Spellberg","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"47","key":"10.1016\/j.biopha.2018.10.075_bib0295","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1016\/j.vaccine.2013.09.016","article-title":"NDV-3 protects mice from vulvovaginal candidiasis through T-and B-cell immune response","volume":"31","author":"Ibrahim","year":"2013","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.biopha.2018.10.075_bib0300","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2018.10.075_bib0305","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1016\/j.vaccine.2010.07.020","article-title":"Principles of vaccine design\u2014lessons from nature","volume":"28","author":"Zepp","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0310","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/520536","article-title":"Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein","volume":"196","author":"Specht","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.10.075_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine technologies: from whole organisms to rationally designed protein assemblies","volume":"120","author":"Karch","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"40","key":"10.1016\/j.biopha.2018.10.075_bib0320","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1016\/j.vaccine.2015.06.117","article-title":"New approaches to understanding the immune response to vaccination and infection","volume":"33","author":"Furman","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0325","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4161\/hv.21838","article-title":"Universal fungal vaccines: could there be light at the end of the tunnel?","volume":"8","author":"Hamad","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.075_bib0330","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0335","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035106","article-title":"Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis","volume":"7","author":"Xin","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0345","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.4161\/hv.25893","article-title":"DNA vaccines: a simple DNA sensing matter?","volume":"9","author":"Coban","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0350","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/iai.65.7.2564-2569.1997","article-title":"Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice","volume":"65","author":"Allendoerfer","year":"1997","journal-title":"Infect. Immun."},{"issue":"15","key":"10.1016\/j.biopha.2018.10.075_bib0355","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1096\/fasebj.12.15.1611","article-title":"Modulating the immune response to genetic immunization","volume":"12","author":"Cohen","year":"1998","journal-title":"Faseb J."},{"issue":"4949","key":"10.1016\/j.biopha.2018.10.075_bib0360","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0365","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.vaccine.2003.11.031","article-title":"Dendritic cell-based vaccination against opportunistic fungi","volume":"22","author":"Bozza","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0370","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bcmd.2004.08.011","article-title":"Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation","volume":"33","author":"Perruccio","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0375","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1172\/JCI38322","article-title":"Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism","volume":"120","author":"McClelland","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"35","key":"10.1016\/j.biopha.2018.10.075_bib0380","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.2174\/092986709789878238","article-title":"Gammadelta T lymphocytes producing IFN\u03b3 and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation","volume":"16","author":"Poggi","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0385","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/529204","article-title":"Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity","volume":"197","author":"Spellberg","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0390","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","article-title":"Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice","volume":"121","author":"W\u00fcthrich","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0395","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2012.04.004","article-title":"Recent progress in vaccines against fungal diseases","volume":"15","author":"Cassone","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0400","doi-asserted-by":"crossref","first-page":"e00035","DOI":"10.1128\/IAI.00035-17","article-title":"Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii","volume":"85","author":"Garvy","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2018.10.075_bib0405","series-title":"Evaluation of the Protective Efficacy of the Killed Coccidioides Immifis Spherule Vaccine in Humans","author":"Williams","year":"1993"},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0410","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","article-title":"The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis","volume":"74","author":"Ibrahim","year":"2006","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0415","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/649901","article-title":"Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein","volume":"201","author":"Baquir","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0425","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0430","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CVI.00480-08","article-title":"Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis","volume":"16","author":"Saville","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"issue":"13","key":"10.1016\/j.biopha.2018.10.075_bib0435","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/pmic.200701056","article-title":"Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice","volume":"8","author":"Mart\u00ednez\u2010L\u00f3pez","year":"2008","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0440","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/iai.51.2.668-674.1986","article-title":"Evidence for macrophage-mediated protection against lethal Candida albicans infection","volume":"51","author":"Bistoni","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2018.10.075_bib0445","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actbio.2016.05.001","article-title":"Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis","volume":"39","author":"Carneiro","year":"2016","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0450","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/314779","article-title":"Candida albicans mannan extract\u2014protein conjugates induce a protective immune response against experimental candidiasis","volume":"179","author":"Han","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0455","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","article-title":"A \u03b2-glucan-conjugate vaccine and anti-\u03b2-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique","volume":"28","author":"Pietrella","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0460","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.vaccine.2008.11.030","article-title":"Anti-\u03b2-glucan antibodies in healthy human subjects","volume":"27","author":"Chiani","year":"2009","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.biopha.2018.10.075_bib0465","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","article-title":"Beta-glucan-CRM197 conjugates as candidates antifungal vaccines","volume":"28","author":"Bromuro","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0470","doi-asserted-by":"crossref","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","article-title":"Protection by anti-\u03b2-glucan antibodies is associated with restricted \u03b2-1, 3 glucan binding specificity and inhibition of fungal growth and adherence","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0475","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.intimp.2007.05.014","article-title":"Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate","volume":"7","author":"Paulovi\u010dov\u00e1","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022030","article-title":"Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus","volume":"6","author":"Cutler","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0485","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/CVI.05215-11","article-title":"Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis","volume":"18","author":"Xin","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0490","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(89)90197-7","article-title":"Phase II study of D. 651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis","volume":"7","author":"Levy","year":"1989","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0495","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/IAI.67.2.826-833.1999","article-title":"Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT (R192G), against systemic candidiasis","volume":"67","author":"C\u00e1rdenas-Freytag","year":"1999","journal-title":"Infect. Immun."},{"issue":"33","key":"10.1016\/j.biopha.2018.10.075_bib0500","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2011.05.030","article-title":"Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice","volume":"29","author":"qing Li","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0505","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1462-5822.2006.00862.x","article-title":"The 65 kDa mannoprotein gene of Candida albicans encodes a putative \u03b2\u2010glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity","volume":"9","author":"Sandini","year":"2007","journal-title":"Cell. Microbiol."},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025909","article-title":"Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis","volume":"6","author":"Luo","year":"2011","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.biopha.2018.10.075_bib0515","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining \u03b2-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0520","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","article-title":"T cell vaccination in mice with invasive pulmonary aspergillosis","volume":"165","author":"Cenci","year":"2000","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0525","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/IAI.01311-10","article-title":"CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine","volume":"79","author":"Diaz-Arevalo","year":"2011","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0530","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/342509","article-title":"Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis","volume":"186","author":"Ito","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.075_bib0535","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1128\/IAI.00815-06","article-title":"Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis","volume":"74","author":"Ito","year":"2006","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0540","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1099\/jmm.0.079681-0","article-title":"Whole glucan particles as a vaccine against murine aspergillosis","volume":"63","author":"Clemons","year":"2014","journal-title":"J. Med. Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0545","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/mmy\/myt015","article-title":"Protection against experimental aspergillosis by heat-killed yeast is not antibody dependent","volume":"52","author":"Clemons","year":"2014","journal-title":"Sabouraudia"},{"issue":"22","key":"10.1016\/j.biopha.2018.10.075_bib0550","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1182\/blood-2010-12-325084","article-title":"Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.biopha.2018.10.075_bib0555","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S1286-4579(02)00007-2","article-title":"Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants","volume":"4","author":"Bozza","year":"2002","journal-title":"Microbes Infect."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0560","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","article-title":"Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination","volume":"183","author":"Bozza","year":"2009","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.biopha.2018.10.075_bib0565","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/S0264-410X(00)00074-8","article-title":"DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from Paracoccidioides brasiliensis","volume":"18","author":"Pinto","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120201","article-title":"Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection","volume":"10","author":"Assis-Marques","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0575","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/IAI.01470-08","article-title":"Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin","volume":"77","author":"Braga","year":"2009","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017885","article-title":"Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis","volume":"6","author":"Fernandes","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2018.10.075_bib0585","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/IAI.00753-07","article-title":"Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection","volume":"76","author":"Soares","year":"2008","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0590","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.vaccine.2009.11.062","article-title":"HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis","volume":"28","author":"Ribeiro","year":"2010","journal-title":"Vaccine"},{"issue":"27\u201330","key":"10.1016\/j.biopha.2018.10.075_bib0595","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1016\/S0264-410X(03)00485-7","article-title":"Identification of a protective antigen of Coccidioides immitis by expression library immunization","volume":"21","author":"Ivey","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0600","doi-asserted-by":"crossref","DOI":"10.1172\/JCI81228","article-title":"CD4+ T cell\u2013independent DNA vaccination against opportunistic infections","volume":"125","author":"Zheng","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0605","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/IAI.67.6.2935-2940.1999","article-title":"Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen","volume":"67","author":"Abuodeh","year":"1999","journal-title":"Infect. Immun."},{"issue":"31\u201332","key":"10.1016\/j.biopha.2018.10.075_bib0610","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.vaccine.2006.04.002","article-title":"Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein","volume":"24","author":"Shubitz","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0615","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","article-title":"A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0620","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/IAI.05726-11","article-title":"Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17)","volume":"79","author":"Hung","year":"2011","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0625","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/IAI.00566-12","article-title":"Construction and evaluation of a novel recombinant T cell epitope-based vaccine against coccidioidomycosis","volume":"80","author":"Hurtgen","year":"2012","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0630","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/IAI.71.6.3010-3019.2003","article-title":"A recombinant \u03b2-1, 3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis","volume":"71","author":"Delgado","year":"2003","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0635","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/IAI.69.5.2878-2887.2001","article-title":"Recombinant Urease and Urease DNA ofCoccidioides immitis Elicit an Immunoprotective Response against Coccidioidomycosis in Mice","volume":"69","author":"Li","year":"2001","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0640","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/IAI.74.3.1865-1872.2006","article-title":"Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate","volume":"74","author":"Orsborn","year":"2006","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0645","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1128\/IAI.00961-06","article-title":"Multivalent recombinant protein vaccine against coccidioidomycosis","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0650","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/iai.4.2.116-125.1971","article-title":"Characterization of antigens from the yeast phase of Histoplasma capsulatum","volume":"4","author":"Garcia","year":"1971","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.075_bib0655","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/iai.15.3.789-795.1977","article-title":"Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum","volume":"15","author":"Tewari","year":"1977","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0660","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/iai.59.1.330-336.1991","article-title":"Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells","volume":"59","author":"Gomez","year":"1991","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0665","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","article-title":"Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum","volume":"112","author":"Nosanchuk","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0670","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/IAI.70.7.3759-3767.2002","article-title":"Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum","volume":"70","author":"Deepe","year":"2002","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0675","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.4049\/jimmunol.169.10.5818","article-title":"The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V\u03b28. 1\/8.2+ T cells","volume":"169","author":"Scheckelhoff","year":"2002","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0680","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/iai.59.12.4459-4464.1991","article-title":"Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells","volume":"59","author":"Gomez","year":"1991","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.075_bib0685","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/iai.60.7.2565-2571.1992","article-title":"An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice","volume":"60","author":"Gomez","year":"1992","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.075_bib0690","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/500244","article-title":"Pulmonary V\u03b24+ T cells from histoplasma capsulatum\u2013infected mice respond to a homologue of Sec31 that confers a protective response","volume":"193","author":"Scheckelhoff","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0695","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1128\/IAI.69.5.3128-3134.2001","article-title":"Protective efficacy of H antigen from histoplasma capsulatum in a Murine model of pulmonary histoplasmosis","volume":"69","author":"Deepe","year":"2001","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.biopha.2018.10.075_bib0700","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","article-title":"Evaluation of Cryptococcus neoformans galactoxylomannan\u2013protein conjugate as vaccine candidate against murine cryptococcosis","volume":"29","author":"Chow","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2018.10.075_bib0705","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3389\/fmicb.2015.00836","article-title":"Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development","volume":"6","author":"Rella","year":"2015","journal-title":"Front. Microbiol."},{"issue":"30","key":"10.1016\/j.biopha.2018.10.075_bib0710","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.vaccine.2005.02.029","article-title":"Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures","volume":"23","author":"Oscarson","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biopha.2018.10.075_bib0715","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.4049\/jimmunol.169.12.6992","article-title":"High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library","volume":"169","author":"Beenhouwer","year":"2002","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.075_bib0720","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.00130-08","article-title":"Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan","volume":"15","author":"Datta","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.075_bib0725","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.166.2.1087","article-title":"A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection","volume":"166","author":"Fleuridor","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.075_bib0730","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/IAI.72.1.196-208.2004","article-title":"Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice","volume":"72","author":"Maitta","year":"2004","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.075_bib0735","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0966-842X(01)02134-5","article-title":"Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens","volume":"9","author":"Pirofski","year":"2001","journal-title":"Trends Microbiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.075_bib0740","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/iai.65.4.1158-1164.1997","article-title":"Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody","volume":"65","author":"Zhang","year":"1997","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.075_bib0745","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-\u03b2-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.075_bib0750","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1139\/w11-023","article-title":"Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats","volume":"57","author":"Feng","year":"2011","journal-title":"Can. J. Microbiol."},{"issue":"11-12","key":"10.1016\/j.biopha.2018.10.075_bib0755","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0264-410X(98)80113-8","article-title":"Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response","volume":"16","author":"Theus","year":"1998","journal-title":"Vaccine"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218353903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218353903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:32:23Z","timestamp":1777876343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218353903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":151,"alternative-id":["S0753332218353903"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.075","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fungal vaccines, mechanism of actions and immunology: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}